NMES for Achilles Tendon Rupture

Description

The majority of patients suffering an Achilles tendon rupture develop long term functional deficits in the affected leg. The goal of the proposed study is to evaluate a new rehabilitation protocol using Neuromuscular Electrical Stimulation (NMES) for reducing muscle atrophy and improving tendon properties. If proven beneficial, the proposed protocol can be easily adopted and incorporated as part of routine care for Achilles tendon rupture.

Conditions

Achilles Tendon Rupture

Talk to us

Study Overview

On this page

Study Details

Study overview

The majority of patients suffering an Achilles tendon rupture develop long term functional deficits in the affected leg. The goal of the proposed study is to evaluate a new rehabilitation protocol using Neuromuscular Electrical Stimulation (NMES) for reducing muscle atrophy and improving tendon properties. If proven beneficial, the proposed protocol can be easily adopted and incorporated as part of routine care for Achilles tendon rupture.

Neuromuscular Electrical Stimulation for Achilles Tendon Rupture Rehabilitation

NMES for Achilles Tendon Rupture

Condition
Achilles Tendon Rupture
Intervention / Treatment

-

Contacts and Locations

State College

Penn State University, State College, Pennsylvania, United States, 16802

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Achilles tendon rupture
  • 1. Those unable to understand spoken English.
  • 2. Participants treated non-operatively
  • 3. Augmented surgical repair (i.e., use of additional tissue at the repair site)
  • 4. Tendon ruptures associated with the use of fluoroquinolones (Examples include ciprofloxacin (Cipro), gemifloxacin (Factive), levofloxacin (Levaquin), moxifloxacin (Avelox), norfloxacin (Noroxin), and ofloxacin (Floxin))
  • 5. Allergy to ultrasound gel
  • 6. Any other condition affecting the ability of the participant to walk or jump
  • 7. Any other health conditions known to impair normal healing: Diabetes, Cardiovascular conditions decreasing blood supply to the leg
  • 8. Those unable to consent

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Penn State University,

Study Record Dates

2024-12-31